parameters were normal. X-ray chest showed ill-defined right mid lower zone opacity diffuse haze in right lung. HRCT (thorax) showed few fibro-parenchymal lesions in B/L upper lobe, B/L pleural effusion seen with collapse consolidation of underlying lung parenchyma. Multiple mildly enlarged paratracheal and pre-tracheal nodes were seen. CECT upper abdomen -liver shows diffuse reduction in parenchymal attenuation with fatty infiltrates of hepatic parenchyma, subtle focal hypodense lesions in segment of VI/VIII of liver with leukaemic deposits.
Introduction
Invasive fungal infection is among the leading causes of morbidity, mortality and economic burden for patients with acute leukaemia. [1] In the past few decades, the incidence of invasive fungal infections (IFIs) has increased dramatically. The certainty of diagnosis of IFIs is based on host factors, clinical evidence and microbiological examination. [2] The complexity of IFI in patients with leukaemia and the limitations of diagnostic tools require a strong clinical suspicion for early diagnosis. IFI management has been further complicated by Non-Aspergillus moulds. In addition even though the antifungal armamentarium has expanded rapidly, the associated motility remains high.
Case Report
Here, we report a case of rare Invasive fungal sepsis by Alternaria alternata in a patient of acute lymphoblastic leukaemia. A 62-year-old male, who presented with complains of fever off and on with poor oral intake, decreased urine output and generalised weakness.
At admission, on examination, he was conscious orientated, responding to verbal commands, febrile, PR -132/min, SPO 2 -100%, BP -100/70 mm, RR -34.
On investigations
The total haemogram -Hb-8.6gm/dl, PCV-24.3%, TLC-1.2/l, RBC count-2.9/L, platelet-0.9/L, RDW-17.9. Peripheral blood had 68% blasts cells. His liver and renal
Discussion
Alternaria is a dematiaceous hyphomycete that is frequently involved in human infection. [3] Alternaria can also be found on normal human and animal skin and conjunctiva. [4] This fungus has been associated frequently with several different types of human infections, e.g. Sino bronchial disease, paranasal sinusitis, ocular infections, onychomycosis, Cutaneous and subcutaneous infections, and, more rarely, granulomatous pulmonary disease, soft palate perforation and disseminated disease. [5] IFI by alternaria is very rare with only a few published case reports.
Prolonged severe neutropenia (<0.5 × 10 9 ), corticosteroids, broad spectrum antibiotics and indwelling intravenous catheters are all important risk factors for the development of disseminated fungal infection. The demonstration of a fungal element or positive culture from a site, in addition to pathological of and clinical evidence of tissue damage establishes fungal infection. Blood culture has very poor sensitivity for detecting moulds. The presence of mould in urine or respiratory tract specimen could simply reflect the presence of contaminants or colonisation. However, a positive culture is considered significance for invasive mycosis in the presence of related clinical signs and symptoms compatible with relevant organisms [ Figure 1 ].
Alternaria is worldwide with many species being common saprophytes in soil, air and variety of other habitats. [6] There is no case report of A. alternata infection from blood culture till date. This is the first case report of disseminated A. alternata infection in acute lymphoblastic leukemia patient.
Cases of Alternaria have responded well to the treatment with the older antifungal drugs, e.g., amphotercin B, flucytosine, flucytosine, fluconzole, miconazole and nystatin. [7] Trends in fungal infection are rapidly changing and novel diagnostic and therapeutic options are emerging. However, several areas in IFI management require further exploration risk stratification based on immogenic factors, the role of new diagnostic modalities, prediction models for differentiating diverse fungal infections and pre-emptive versus empirical therapy. [7, 8] In order to optimise our diagnostic and therapeutic management of IFI in patients with acute leukaemia, further basic research and clinical trials are desperately needed.
